{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T02:35:34Z","timestamp":1770345334073,"version":"3.49.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Coronavirus disease 2019 has been reported to be a prothrombotic condition; however, multicenter data comparing this with other viral pneumonias in those requiring extracorporeal membrane oxygenation are lacking. We conducted a multicenter study using whole-body CT to examine the prevalence, severity, and nature of vascular complications in coronavirus disease 2019 in comparison with patients with other viral pneumonias.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>We analyzed whole-body CT scans for the presence of vascular thrombosis (defined as pulmonary artery thrombus, venous thrombus, systemic arterial thrombus, or end-organ infarct). The severity, distribution, and morphology of pulmonary artery thrombus were characterized. Competing risk cumulative incidence analysis was used to compare survival with discharge.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Three centers of the English national extracorporeal membrane oxygenation service.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Consecutive patients admitted with either coronavirus disease 2019 or noncoronavirus disease 2019 viral pneumonia admitted from January 2019.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>One-hundred thirty-six patients (45.2 \u00b1 10.6 yr old, 39\/146 [27%] female) requiring extracorporeal membrane oxygenation support underwent whole-body CT scans at admission. Of these, 86 had coronavirus disease 2019 pneumonia, and 50 had noncoronavirus disease 2019 viral pneumonia. Vascular thrombosis was seen more often in patients with coronavirus disease 2019 (odds ratio, 12.9 [95% CI 4.5\u201336.8]). In those with coronavirus disease 2019, 57 (73%) demonstrated pulmonary artery thrombus or pulmonary perfusion defects. Eighty-two percent of thrombus exhibited emboli-like morphology. The location of pulmonary artery thrombus and parenchymal perfusion defects was only concordant in 30% of cases. The risk of mortality was higher in those with coronavirus disease 2019 compared with noncoronavirus disease 2019 pneumonia (\u03c7<jats:sup>2<\/jats:sup> = 3.94; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.047). Mortality was no different in coronavirus disease 2019 patients with or without vascular thrombosis (\u03c7<jats:sup>2<\/jats:sup> = 0.44; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.51).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>In patients who received extracorporeal membrane oxygenation, coronavirus disease 2019 is associated with a higher prevalence of vascular thrombosis compared with noncoronavirus disease viral pneumonias. The pattern of pulmonary vascular changes suggests concurrent embolic disease and small vessel disease. Despite this, vascular thrombosis was not linked to poorer short-term prognosis in those with coronavirus disease 2019.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000005322","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T17:46:59Z","timestamp":1632851219000},"page":"624-632","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Vascular Thrombosis in Severe COVID-19 Requiring Extracorporeal Membrane Oxygenation: A Multicenter Study"],"prefix":"10.1097","volume":"50","author":[{"given":"Jonathan R.","family":"Weir-McCall","sequence":"first","affiliation":[{"name":"Royal Papworth Hospital, Cambridge, United Kingdom."},{"name":"University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Galea","sequence":"additional","affiliation":[{"name":"Royal Papworth Hospital, Cambridge, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sze","family":"Mun Mak","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas' NHS Foundation Trust, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kushal","family":"Joshi","sequence":"additional","affiliation":[{"name":"University Hospitals of Leicester NHS Trust, Leicester, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobby","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Royal Papworth Hospital, Cambridge, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Screaton","sequence":"additional","affiliation":[{"name":"Royal Papworth Hospital, Cambridge, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Toshner","sequence":"additional","affiliation":[{"name":"Royal Papworth Hospital, Cambridge, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Ruggiero","sequence":"additional","affiliation":[{"name":"Royal Papworth Hospital, Cambridge, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Benedetti","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas' NHS Foundation Trust, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Brozik","sequence":"additional","affiliation":[{"name":"University Hospitals of Leicester NHS Trust, Leicester, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Machin","sequence":"additional","affiliation":[{"name":"University Hospitals of Leicester NHS Trust, Leicester, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indrajeet","family":"Das","sequence":"additional","affiliation":[{"name":"University Hospitals of Leicester NHS Trust, Leicester, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marusa","family":"Kotnik","sequence":"additional","affiliation":[{"name":"Royal Papworth Hospital, Cambridge, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Sun","sequence":"additional","affiliation":[{"name":"Royal Papworth Hospital, Cambridge, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mackay","sequence":"additional","affiliation":[{"name":"Royal Papworth Hospital, Cambridge, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Jacob","sequence":"additional","affiliation":[{"name":"Centre for Medical Image Computing, University College London, London, United Kingdom."},{"name":"UCL Respiratory, University College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan C. L.","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Royal United Hospital Bath NHS Foundation Trust, Bath, United Kingdom."},{"name":"Department of Health, University of Bath, Bath, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Camporota","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas' NHS Foundation Trust, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Vuylsteke","sequence":"additional","affiliation":[{"name":"Royal Papworth Hospital, Cambridge, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"100639","DOI":"10.1016\/j.eclinm.2020.100639","article-title":"Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis [Internet].","volume":"29\u201330","author":"Malas","year":"2020","journal-title":"EClinicalMedicine"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.2214\/AJR.09.3599","article-title":"Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection.","volume":"193","author":"Agarwal","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1097\/CCM.0b013e3181eb9d2b","article-title":"Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units.","volume":"38","author":"Walsh","year":"2010","journal-title":"Crit Care Med"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19.","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"2001608","DOI":"10.1183\/13993003.01608-2020","article-title":"Thrombosis and COVID-19 pneumonia: The clot thickens!","volume":"56","author":"Price","year":"2020","journal-title":"Eur Respir J"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19.","volume":"76","author":"Paranjpe","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.7861\/clinmed.2020-0228","article-title":"Thrombotic risk in COVID-19: A case series and case\u2013Control study.","volume":"20","author":"Stoneham","year":"2020","journal-title":"Clin Med (Northfield Il)"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"2001365","DOI":"10.1183\/13993003.01365-2020","article-title":"Pulmonary embolism in patients with COVID-19 pneumonia.","volume":"56","author":"Bompard","year":"2020","journal-title":"Eur Respir J"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.","volume":"18","author":"Cui","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19.","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study.","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/CCM.0000000000004890","article-title":"Prevalence of thrombotic complications in ICU-treated patients with coronavirus disease 2019 detected with systematic CT scanning.","volume":"49","author":"Mirsadraee","year":"2021","journal-title":"Crit Care Med"},{"key":"R14-20250502","first-page":"804","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19.","volume":"49","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"R15-20250502","first-page":"M20","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19.","volume":"25","author":"Wichmann","year":"2020","journal-title":"Ann Intern Med"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2020.05.018","article-title":"Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels.","volume":"192","author":"Demelo-Rodr\u00edguez","year":"2020","journal-title":"Thromb Res"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.120.046702","article-title":"Deep vein thrombosis in hospitalized patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: Prevalence, risk factors, and outcome.","volume":"142","author":"Zhang","year":"2020","journal-title":"Circulation"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2020.05.053","article-title":"High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients.","volume":"76","author":"Voicu","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.121.318902","article-title":"SARS-CoV-2 Spike protein impairs endothelial function via downregulation of ACE 2.","volume":"128","author":"Lei","year":"2021","journal-title":"Circ Res"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Pulmonary embolism in patients with COVID-19: Awareness of an increased prevalence.","volume":"142","author":"Poissy","year":"2020","journal-title":"Circulation"},{"key":"R21-20250502","article-title":"Therapeutic anticoagulation in critically ill patients with COVID-19 \u2013 Preliminary report.","year":"2021","journal-title":"medRxiv"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2021.4152","article-title":"Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: The INSPIRATION randomized clinic.","volume":"325","author":"Sadeghipour","year":"2021","journal-title":"JAMA"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1164\/rccm.202004-1412OC","article-title":"Pulmonary angiopathy in severe COVID-19: Physiologic, imaging, and hematologic observations.","volume":"202","author":"Patel","year":"2020","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000005322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T18:03:15Z","timestamp":1746208995000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000005322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000005322","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,27]]}}}